2018
DOI: 10.1016/j.cis.2018.09.002
|View full text |Cite
|
Sign up to set email alerts
|

Recent progress in the engineering of multifunctional colloidal nanoparticles for enhanced photodynamic therapy and bioimaging

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

0
48
0

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

1
8

Authors

Journals

citations
Cited by 62 publications
(48 citation statements)
references
References 170 publications
0
48
0
Order By: Relevance
“…Considered as simple drug carrier in most works, nanoparticles are presently designed to achieve several functions [Mura et al, 2013, Mura and Couvreur 2016a, Lamch et al, 2018, Hu et al, 2018.…”
Section: Bypassing the Cell Membrane Of Multidrug Resistant Cancer Cellsmentioning
confidence: 99%
See 1 more Smart Citation
“…Considered as simple drug carrier in most works, nanoparticles are presently designed to achieve several functions [Mura et al, 2013, Mura and Couvreur 2016a, Lamch et al, 2018, Hu et al, 2018.…”
Section: Bypassing the Cell Membrane Of Multidrug Resistant Cancer Cellsmentioning
confidence: 99%
“…Most ongoing clinical trials concern treatments of various cancers caused by solid tumors. In general, nanomedicines are developed as drug delivery systems, but several projects concern nanomaterials to be used in cancer radiotherapy [Hainfeld et al, 2014, Mi et al, 2016, Lacombe et al, 2017, Lamch et al, 2018. Beside treating cancers and infections, nanomedicines hold promise to improve the life of patients suffering from brain diseases [Andrieux and Couvreur, 2013, Kreuter, 2014, Savaira et al, 2016, Zhou et al, 2018, cardiovascular diseases [Ferreira et al, 2015, Suarez et al, 2015, Varna et al, 2015, Chan et al, 2018, Cicha et al, 2018, Dormont et al, 2018 and metabolic diseases [Pridgen et al, 2015, Aguirre et al, 2016, Wong et al, 2017.…”
Section: Introductionmentioning
confidence: 99%
“…However, as reported by Zhang et al in a recent review [18], clinical development of PDT remains somewhat limited because of various challenges, ranging from photosensitizer formulation, light dosimetry, to planning and monitoring the treatment [15,[18][19][20][21][22]. Some of these points have been recently reviewed: ideal photosensitizers [23], challenges in formulating photosensitizers, and choosing the right light dosimetry [24], as well as monitoring the treatment response [25]. Among all these, the adaptation of light source and dosimetry is currently a very active field.…”
Section: Introductionmentioning
confidence: 99%
“…The work reported here extends our studies on new methodologies and techniques regarding biopharmaceuticals and new biocompatible drug nanocarriers. 25 29 In the present contribution, horseweed has been selected as a source of plant-originated functional food fiber. Moreover, its easy availability and the fact that this weed is a common issue in agriculture draw attention to the need for development of this valuable bioresource.…”
Section: Introductionmentioning
confidence: 99%